Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Mann

Showing results (91-100 of 254) with videos related to

Pageof 26
Sort By:
European Addiction Research|April 9, 2018
Global Scientific Production on Illicit Drug Addiction: A Two-Decade AnalysisMalahat Khalili, Afarin Rahimi-Movaghar, Behrang Shadloo, et al.
Biological Psychiatry|January 24, 2007
Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis usersDerik Hermann, Alexander Sartorius, Helga Welzel, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|October 1, 2010
Effects of repeated withdrawal from alcohol on recovery of cognitive impairment under abstinence and rate of relapseSabine Loeber, Theodora Duka, Helga Welzel Márquez, et al.
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|August 10, 2002
[The qualified-detoxification-of-alcoholics procedure--in light of the development of guidelines for the treatment of substance-related disorders]Lutz G Schmidt, Götz Mundle, Markus Banger, et al.
Expert Opinion on Drug Safety|February 6, 2015
Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programmeWim van den Brink, John Strang, Antoni Gual, et al.
Drug and Alcohol Dependence|January 18, 2024
Corrigendum to "Examining a brief measure and observed cutoff scores to identify reward and relief drinking profiles: Psychometric properties and pharmacotherapy response" [Drug Alcohol Depend. 232 (2022) 109257]Victoria R Votaw, Karl Mann, Henry R Kranzler, et al.
Expert Opinion on Drug Safety|December 24, 2019
Safety of nalmefene for the treatment of alcohol use disorder: an updateHugo López-Pelayo, Paola Zuluaga, Elsa Caballeria, et al.
Alcoholism, Clinical and Experimental Research|August 6, 2019
Response to Dr. Mark Litt's CommentaryRaymond F Anton, Katie Witkiewitz, Daniel Falk, et al.
Alcoholism, Clinical and Experimental Research|May 24, 2011
Effects of alcoholism and continued abstinence on brain volumes in both gendersTraute Demirakca, Gabriele Ende, Nina Kämmerer, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|July 23, 2013
Efficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: results from a subgroup analysis of two randomized controlled 6-month studiesWim van den Brink, Henri-Jean Aubin, Anna Bladström, et al.
Pageof 26

Showing results (91-100 of 254) with videos related to

Sort By:
Pageof 26
European Addiction Research|April 9, 2018
Global Scientific Production on Illicit Drug Addiction: A Two-Decade AnalysisMalahat Khalili, Afarin Rahimi-Movaghar, Behrang Shadloo, et al.
Biological Psychiatry|January 24, 2007
Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis usersDerik Hermann, Alexander Sartorius, Helga Welzel, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|October 1, 2010
Effects of repeated withdrawal from alcohol on recovery of cognitive impairment under abstinence and rate of relapseSabine Loeber, Theodora Duka, Helga Welzel Márquez, et al.
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|August 10, 2002
[The qualified-detoxification-of-alcoholics procedure--in light of the development of guidelines for the treatment of substance-related disorders]Lutz G Schmidt, Götz Mundle, Markus Banger, et al.
Expert Opinion on Drug Safety|February 6, 2015
Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programmeWim van den Brink, John Strang, Antoni Gual, et al.
Drug and Alcohol Dependence|January 18, 2024
Corrigendum to "Examining a brief measure and observed cutoff scores to identify reward and relief drinking profiles: Psychometric properties and pharmacotherapy response" [Drug Alcohol Depend. 232 (2022) 109257]Victoria R Votaw, Karl Mann, Henry R Kranzler, et al.
Expert Opinion on Drug Safety|December 24, 2019
Safety of nalmefene for the treatment of alcohol use disorder: an updateHugo López-Pelayo, Paola Zuluaga, Elsa Caballeria, et al.
Alcoholism, Clinical and Experimental Research|August 6, 2019
Response to Dr. Mark Litt's CommentaryRaymond F Anton, Katie Witkiewitz, Daniel Falk, et al.
Alcoholism, Clinical and Experimental Research|May 24, 2011
Effects of alcoholism and continued abstinence on brain volumes in both gendersTraute Demirakca, Gabriele Ende, Nina Kämmerer, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|July 23, 2013
Efficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: results from a subgroup analysis of two randomized controlled 6-month studiesWim van den Brink, Henri-Jean Aubin, Anna Bladström, et al.
Pageof 26